Journal of Thrombosis and Thrombolysis

Papers
(The median citation count of Journal of Thrombosis and Thrombolysis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team27
Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry26
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series25
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients24
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding16
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies14
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison14
Forensic autopsy-confirmed thrombosis-related deaths: the danger in the bones13
Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell’s viper venom time and silica clotting time increases thrombotic risk prediction12
Popliteal cysts are not a risk factor for lower extremity deep vein thrombosis12
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study11
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period11
Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type10
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes10
Modelling the procoagulatory effect of Anastrozole relative to ERα and ERβ expression in breast cancer cells9
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials9
Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity8
Correction to: Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension8
0.058726072311401